Liangqing Yao

Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1

Jiajia Li, Xiuling Zhi, Xiaoqing Shen et al. · Biochemical and Biophysical Research Communications · 2019 · 69 citations · Full text

Medicine, Cancer Biology, Oncology +14

miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1

Haosha Tang, Liangqing Yao, Xiang Tao et al. · International Journal of Molecular Medicine · 2013 · 68 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

An Efficient Route to 3‐Amidylindoles <i>via</i> a Palladium‐ Catalyzed Tandem Reaction of 2‐Alkynylanilines with Isocyanides

Guanyinsheng Qiu, Chen Chen, Liangqing Yao et al. · Advanced Synthesis & Catalysis · 2013 · 65 citations

Natural Sciences, Chemistry, Catalysis +6

Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer

Ruoyao Zou, Qidi Jiang, Tianqiang Jin et al. · Frontiers in Immunology · 2022 · 61 citations · Full text

Medicine, Immunology, Oncology +17

Synthesis of sulfonated naphthols <i>via</i> C–H bond functionalization with the insertion of sulfur dioxide

Kaida Zhou, Mo Chen, Liangqing Yao et al. · Organic Chemistry Frontiers · 2017 · 56 citations

Natural Sciences, Chemical Engineering, Chemistry +10